Professor 黃炳鏐 was honored in June 2023 with the "2023 Global Outstanding Overseas Chinese Student Alumni Academic Achievement Award" to recognize his over forty years of academic contributions and his ongoing exceptional contributions to the field of biotechnology.
Born in Guangzhou in 1947, Professor Huang later moved to Hong Kong and attended the 香港大同中學. It was here that he received his initial exposure to the field of science and technology. Due to his outstanding performance, he was granted admission to the Chemical Engineering Department at National Taiwan University. In 1969, he received a full scholarship to pursue his studies in the Department of Chemical Engineering at Tufts University in the United States, and he obtained his doctoral degree in 1973. Subsequently, he entered the private sector, serving as a research director and also holding a position as a visiting professor at Tufts University.
Despite his international acclaim in the scientific community, Professor Huang has always maintained a deep sense of gratitude and cherished the land of Taiwan that nurtured him. In the 1980s and 1990s, he actively participated in activities within the overseas Chinese community in the United States, demonstrating his genuine dedication to giving back to society. As a renowned scholar in the international biotechnology field, he has held positions as a technical and research director in several large corporations and has achieved over a hundred patented technologies. Among these accomplishments, his development of the artificial blood "Hemopure" is particularly well-known. Approved by the U.S. Food and Drug Administration in 1999, this product has been widely used in veterinary medicine and is currently undergoing human clinical trials, offering hope for clinical treatments. In fact, it has already been applied in clinical practice through the "Compassionate Use" pathway, successfully saving the lives of hundreds. In recent years, he has also introduced "Alcolear," originally designed to treat alcoholic fatty liver disease, as a health product in the market.
Professor Huang's contributions, including his efforts in building community housing and promoting commercial development to settle overseas Chinese, as well as his commitment to integrating new and old overseas Chinese communities and dedicating himself to the research and development of artificial blood technology, have deservedly led to his recognition as the recipient of the "2023 Global Outstanding Overseas Chinese Student Alumni Academic Achievement Award."
Regarding this honor, Professor Huang expressed deep gratitude. He stated that he has no regrets and looks forward to witnessing the formal market introduction of the artificial blood technology during his lifetime, bringing hope to address the issue of blood shortages.
